Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals

American Journal of Veterinary Research

Volumn 58, Issue 1, 1997, Pages 56-61

  Lakritz, Jeffrey ^a   Wilson, W David ^a   Watson, Johanna L ^a   Hyde, Dallas M ^a   Mihalyi, Judy ^a   Plopper, Charles G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANHYDROERYTHROMYCIN A; ERYTHROMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; HORSE; INFLAMMATION; LUNG LAVAGE; NONHUMAN; ORAL DRUG ADMINISTRATION; VETERINARY MEDICINE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL ADHESION; ENDOSCOPY; ERYTHROMYCIN; FEMALE; HORSE DISEASES; HORSES; INFLAMMATION; MALE; NEUTROPHILS; RANDOM ALLOCATION;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0031033059     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Yager JA. The pathogenesis of Rhodococcus equi pneumonia in foals. Vet Microbiol 1987;14:225-232.
2. Ainsworth DM, Beck KA, Boatwright CE, et al. Lack of residual lung damage in horses in which Rhodococcus equ-induced pneumonia had been diagnosed. Am J Vet Res 1993;54:2115-2120.
3. Washington JA, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1 of 2). Mayo Clin Proc 1985;60:189-203.
4. Washington JA, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2 of 2). Mayo Clin Proc 1985;60:271-278.
5. Oda H, Kadota Ji, Kohno S, et al. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest 1994;106:1116-1123.
6. Nelson S, Summer WR, Terry PB, et al. Erythromycin-nduced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1987;136:1207-1212.
7. Mandell LA. Effects of antimicrobial and antineoplastic drugs on the phagosome and microbiocidal function of the polymorphonuclear leukocyte. Rev Infect Dis 1982;4:683-685.
8. Ras GJ, Anderson R, Taylor GW, et al. Clindamycin, erythromycin and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro. Antimicrob Agents Chemother 1992;36:1236-1240.
9. Webster GF, Leyden JJ, McGinley KJ, et al. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erythromycin. Antimicrob Agents Chemother 1982;21:770-772.
10. Fagon J-Y, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture technique. Am Rev Respir Dis 1989;139:877-884.
11. Byars D. A practical approach to medical problems of horses, in Proceedings, 6th Annu Symp Adv Clin Med 1993;9-14.
12. Lakritz J, Wilson WD, Berry CR, et al. Bronchointersititial pneumonia and respiratory distress in young horses: clinical, clinicopathologic, radiographic and pathologic findings in 23 cases (1984-1989). J Vet Intern Med 1993;7:277-288.
13. Ainsworth DM, Weldon AD, Beck KA, et al. Recognition of Pneumocystis carnii in foals with respiratory distress. Equine Vet J 1993;25:103-108.
14. Liu IKM, Walsh EM, Bernoco M, et al. Bronchoalveolar lavage in the newborn foal. J Reprod Fertil 1987;35(Suppl):587-592.
15. Boyden S. The chemotactic efffet of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 1962;115:453-466.
16. Latimer KS, Crane LS, Prasse KW. Quantitative evaluation of noutrophilic chemotaxis in Beagles. Am J Vet Res 1981;42:1234-1256.
17. Sammak PJ, Gorbsky GJ, Borisy GG. Microtubule dynamics in vivo: a test of turnover. Cell Biol 1987;104:395-405.
18. Jandel Corporation. SigmaStat for Windows, San Rafael, Calif: Jandel Corp, 1992 1994;7, 73-77, 90.
19. Zink MC, Johnson JA, Prescott JF, et al. The interaction of Corynebacterium equi and equine alveolar macrophages in vitro. J Reprod Fertil Suppl 1982;32:491-496.
20. Zink MC, Yager JA, Prescott JF, et al. In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals. Am J Vet Res 1985;46:2171-2174.
21. Traub-Dargatz JL, McKinnon AO, Bruyninchx WJ, et al. Effect of transportation stress on bronchoalveolar lavage fluid analysis in female horses. Am J Vet Res 1988;49:1026-1029.
22. Mair TS, Stokes CR, Bourne FJ. Cellular content of secretions obtained by lavage from different levels of the equine respiratory tract. Equine Vet J 1987;19:458-462.
23. Fels AOS, Cohn ZA. The alveolar macrophage. J Appl Physiol 1986;60:353-369.
24. Sweeney CR, Rossier Y, Ziemer EL, et al. Effect of prior lung lavage on bronchoalveolar lavage fluid cell population of lavaged and unlavaged lung segments in horses. Am J Vet Res 1994;55:1501-1504.
25. Zink MC, Johnson JA. Cellular constituents of clinically normal foal bronchoalveolar lavage fluid during postnatal maturation. Am J Vet Res 1984;45:89-97.
26. Derksen FJ, Scott JS, Miller DC, et al. Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves). Am Rev Respir Dis 1985;132:1066-1070.
27. Sweeney CR, Leary HJ, Ziemer EL, et al. Effect of water vapor saturated air therapy on bronchoalveolar lavage and tracheal mucous transport rate in clinically normal horses. Am J Vet Res 1989;50:276-279.
28. Roche Y, Gougerot-Pocidalo MA, Fay M, et al. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation. J Antimicrob Chemother 1986;17:195-203.
29. Umeki S. Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil NADPH-oxidase activity. Chest 1993;104:1191-1193.
30. Goswani SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 1990;141:72-78.
31. Ichikawa Y, Ninomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992;146:196-203.
32. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 1989;159:966-973.
33. Keicho N, Kudoh S, Yotsumoto H, et al. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot 1993;46:1406-1413.
34. Stupans I, Sansom LN. The inhibition of drug oxidation by anhydroerythromycin, an acid depredation product of erythromycin. Biochem Pharm 1991;42:2085-2090.
35. Whitwell K. Pneumocystis carnii infection in foals in the United Kingdom (letter). Vet Rec 1992;131:19.
36. Prescott JF, Immunodeficiency and serious pneumonia in foals: the plot thickens. Equine Vet J 1993;25:88-89.
37. Turk J, Miller M, Brown T, et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988). J Am Vet Med Assoc 1990;196:771-773.